Edition:
United States

People: Safran SA (SAF.PA)

SAF.PA on Paris Stock Exchange

66.54EUR
9 Dec 2016
Change (% chg)

€0.07 (+0.11%)
Prev Close
€66.47
Open
€66.45
Day's High
€66.56
Day's Low
€65.95
Volume
751,165
Avg. Vol
888,112
52-wk High
€67.12
52-wk Low
€48.87

McInnes, Ross 

Mr. Ross McInnes is Chairman of the Board of Directors at SAFRAN S.A. since April 23, 2015. He started his career in 1977 with Kleinwort Benson bank, first of all in London then in Rio de Janeiro. In 1980, he joined Continental Bank (now Bank of America) in which he held several positions as Vice President in the corporate finance arm, in Chicago and then in Paris. In 1989, he chose to move to large multinational corporations and became Chief Financial Officer of Ferruzzi Corporation of America. The Ferruzzi Group controlled, in particular, Eridania Beghin-Say, of which he was appointed Chief Financial Officer in 1991, then a member of the Board of Directors in 1999. The following year, he joined Thomson-CSF (now Thales) as Executive Vice President and Chief Financial Officer and assisted in the group’s transformation until 2005. He then moved to PPR (Pinault-Printemps-La Redoute, now Kering) as Senior Vice President for Finance and Strategy, before joining the Supervisory Board of Generale de Santé in 2006. At the request of the Supervisory Board, he served as acting Chairman of the Management Board of Generale de Santé from March to June 2007. He subsequently held the position of Vice-Chairman of Macquarie Capital Europe, notably specializing in infrastructure investments. In March 2009, Ross McInnes joined Safran as special Advisor to the Chairman of the Executive Board, before becoming Executive Vice President, Economic and Financial Affairs in June of that year. He was a member of the Executive Board of Safran between July 2009 and April 2011.

Basic Compensation

Total Annual Compensation, EUR 1,054,780
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 1,054,780

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --